Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:e63
Published online before print January 31, 2008, doi: 10.1161/STROKEAHA.107.511824
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/3/e63    most recent
STROKEAHA.107.511824v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olsen, T. S.
Right arrow Articles by Andersen, K. K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Olsen, T. S.
Right arrow Articles by Andersen, K. K.

(Stroke. 2008;39:e63.)
© 2008 American Heart Association, Inc.


Letters to the Editor

Response to Letter by Sheikh

Tom Skyhøj Olsen, MD, PhD

The Stroke Unit, Department of Neurorehabilitation, Hvidovre University Hospital, Hvidovre, Denmark

Rune Haubo Bojesen Christensen, MS

Technical University of Denmark, Lyngby, Denmark

Lars Peter Kammersgaard, MD

The Stroke Unit, Department of Neurorehabilitation, Hvidovre University Hospital, Hvidovre, Denmark

Klaus Kaae Andersen, MS, PhD

Technical University of Denmark, Lyngby, Denmark


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Response:

We appreciate Dr Sheikh’s thoughtful comments on our work.1 The key issue is whether or not total serum cholesterol (TSC) taken within 24 hours after a stroke reflects usual cholesterol levels. There are pros and cons. This is discussed in the article. It is important to note, however, that a correlation between stroke severity and an alteration in the lipid profile in the first few days after the stroke has not been demonstrated (Reference 30 in the article). Dr Sheikh claims that poststroke TSC levels are not representative of the levels before onset of the arterial disease, but he does not provide proof of his claim. It is premature, therefore, to deem our findings unreliable and misleading.

In line with others, we found that TSC measured within 24 hours after an ischemic stroke was inversely related to outcome (References 17 to 19 in the article). A neuroprotective role of cholesterol was suggested as an explanation of this finding. We observed an almost linear association between cholesterol and stroke severity—higher cholesterol levels were associated with smaller stroke. Hence, we instead propose the hypothesis that cholesterol primarily gives rise to smaller stroke (with a better prognosis).

When looking for the link between cholesterol and stroke, many large-scale studies have handled stroke as one entity (Reference 9 in the article). We now know that TSC in patients with hemorrhagic stroke is lower than in patients with ischemic stroke—this is widely accepted and also the finding in our study (unpublished).2 Therefore, hemorrhagic and . . . [Full Text of this Article]